US EditionPublished • loading... • Updated
First Commercial Use of Plozasiran for Familial Chylomicronemia Syndrome Administered at Stony Brook Medicine
Summary by GeneOnline News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
First Commercial Use of Plozasiran for Familial Chylomicronemia Syndrome Administered at Stony Brook Medicine
The first commercial administration of plozasiran, a tr […] The post First Commercial Use of Plozasiran for Familial Chylomicronemia Syndrome Administered at Stony Brook Medicine first appeared on GeneOnline News. The post First Commercial Use of Plozasiran for Familial Chylomicronemia Syndrome Administered at Stony Brook Medicine appeared first on GeneOnline News.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
